Improving the diagnostic accuracy of N-terminal B-type natriuretic peptide in human systolic heart failure by plasma profiling using mass spectrometry

Journal of Proteome Research

Volumn 6, Issue 8, 2007, Pages 3329-3334

  Jones, Donald J L ^a   Willingale, Richard ^b   Quinn, Paulene A ^c   Lamb, John H ^a   Farmer, Peter B ^a   Davies, Joan E ^c   Ng, Leong L ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Mass spectrometry; Natriuretic peptides; Sensitivity; Specificity; Systolic heart failure

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE;

AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; ROC CURVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34548189840     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070023d     Document Type: Article

References (18)

1. Latour-Perez, J.; Coves-Orts, F. J.; Abad-Terrado, C.; Abraira, V.; Zamora, J. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: A systematic review. Eur. J. Heart Failure 2006, 8, 390-399.
2. Wang, C. S.; FitzGerald, J. M.; Schulzer, M.; Mak, E.; Ayas, N. T. Does this dyspneic patient in the emergency department have congestive heart failure? J. Am. Med. Assoc. 2005, 294, 1944-1956.
3. Silver, M. A.; Maisel, A.; Yancy, C. W.; McCullough, P. A.; Burnett, J. C. Jr.; Francis, G. S.; Mehra, M. R.; Peacock, W. F., 4th; Fonarow, G.; Gibler, W. B.; Morrow, D. A.; Hollander, J. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congestive Heart Failure 2004, 10(5 Suppl 3), 1-30.
4. Sabatine, M. S.; Morrow, D. A.; de Lemos, J. A.; Gibson, C. M.; Murphy, S. A.; Rifai, N.; McCabe, C.; Antman, E. M.; Cannon, C. P.; Braunwald, E. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactlve protein, and B-type natriuretic peptide. Circulation 2002, 105, 1760-1763.
5. Petricoin, E. F.; Ardekani, A. M.; Hitt, B. A.; Levine, P. J.; Fusaro, V. A.; Steinberg, S. M.; Mills, B. G.; Simone, C.; Fishman, D. A.; Kohn, E. C.; Liotta, L. A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
6. Zhang, Y. F.; Wu, D. L.; Guan, M.; Liu, W. W.; Wu, Z.; Chen, Y. M.; Zhang, W. Z.; Lu, Y. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin. Biochem. 2004, 37, 772-779.
7. Villanueva, J.; Philip, J.; Entenberg, D.; Chaparro, C. A.; Tanwar, M. K.; Holland, E. C.; Tempst, P. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 2004, 76(6), 1560-1570.
8. Villanueva, J.; Philip, J.; Chaparro, C. A.; Li, Y. B.; Toledo-Crow, R.; DeNoyer, L.; Fleisher, M.; Robbins, R.; Tempst, P. Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 2005, 4(4), 1060-1072.
9. Jaffe, A. S.; Babuin, L.; Apple, F. S. Biomarkers in acute cardiac disease - The present and the future. J. Am. Coll. Cardiol. 2006, 48(1), 1-11.
10. Arab, S.; Gramolini, A. O.; Ping, P.; Kislinger, T.; Stanley, B.; van Eyk, J.; Ouzounian, M.; MacLennan, D. H.; Emili, A.; Liu, P. P. Cardiovascular proteomics - Tools to develop novel biomarkers and potential applications. J. Am. Coll. Cardiol. 2006, 48(9), 1733-1741.
11. McGregor, E.; Dunn, M. J. Proteomics of the heart - Unraveling disease. Circ. Res. 2006, 98(3), 309-321.
12. Willingale, R.; Jones, D. J. L.; Lamb, J. H.; Quinn, P.; Farmer, P. B.; Ng, L. L. Searching for biomarkers of heart failure in the mass spectra of blood plasma. Proteomics 2006, 6(22), 5903-5914.
13. Mateos-Caceres, P. J.; Garcia-Mendez, A.; Farre, A. L.; Macaya, C.; Nunez, A.; Gomez, J.; Alonso-Orgaz, S.; Carrasco, C.; Burgos, M. E.; de Andres, R.; Granizo, J. J.; Farre, J.; Rico, L. A. Proteomic analysis of plasma from patients during an acute coronary syndrome. J. Am. Coll. Cardiol. 2004, 44, 1578-1583.
14. Kislinger, T.; Gramolini, A. O.; MacLennan, D. H.; Emili, A. Multidimensional protein identification technology (MudPIT): Technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J. Am. Soc. Mass Spectrom. 2005, 8, 1207-1220.
15. Abdul-Salam, V. B.; Paul, G. A.; Ali, J. O.; Gibbs, S. R.; Rahman, D.; Taylor, G. W.; Wilkins, M. R.; Edwards, R. J. Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics 2006, 6, 2286-2294.
16. Ng, L. L.; Loke, I.; Davies, J. E.; Khunti, K.; Stone, M.; Abrams, K. R.; Chin, D. T.; Squire, I. B. Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiography. Eur. J. Heart Failure 2003, 5, 775-782.
17. Hanley, J. A.; McNeil, B. J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148, 839-843.
18. Witten, I. H.; Frank, E. Data Mining: Practical machine learning tools and techniques, 2nd ed; Morgan Kaufmann: San Francisco, 2005.